344 related articles for article (PubMed ID: 16918124)
1. Molecular genetics of bladder cancer: targets for diagnosis and therapy.
Baffa R; Letko J; McClung C; LeNoir J; Vecchione A; Gomella LG
J Exp Clin Cancer Res; 2006 Jun; 25(2):145-60. PubMed ID: 16918124
[TBL] [Abstract][Full Text] [Related]
2. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
3. Molecular alterations associated with bladder cancer progression.
Sánchez-Carbayo M; Cordon-Cardó C
Semin Oncol; 2007 Apr; 34(2):75-84. PubMed ID: 17382791
[TBL] [Abstract][Full Text] [Related]
4. Bladder cancer: translating molecular genetic insights into clinical practice.
Cheng L; Zhang S; MacLennan GT; Williamson SR; Lopez-Beltran A; Montironi R
Hum Pathol; 2011 Apr; 42(4):455-81. PubMed ID: 21106220
[TBL] [Abstract][Full Text] [Related]
5. Molecular targeting and pharmacogenomics in the management of advanced bladder cancer.
Raghavan D
Cancer; 2003 Apr; 97(8 Suppl):2083-9. PubMed ID: 12673700
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of invasive bladder cancers: histological and molecular markers.
Liebert M; Seigne J
Semin Urol Oncol; 1996 May; 14(2):62-72. PubMed ID: 8734733
[TBL] [Abstract][Full Text] [Related]
7. Molecular targeting in the treatment of either advanced or metastatic bladder cancer or both according to the signalling pathways.
Wallerand H; Reiter RR; Ravaud A
Curr Opin Urol; 2008 Sep; 18(5):524-32. PubMed ID: 18670279
[TBL] [Abstract][Full Text] [Related]
8. Genetic alterations as clonal markers for bladder cancer detection in urine.
Mao L
J Cell Biochem Suppl; 1996; 25():191-6. PubMed ID: 9027618
[TBL] [Abstract][Full Text] [Related]
9. Alterations of tumor suppressor genes in bladder cancer.
Cordon-Cardo C; Reuter VE
Semin Diagn Pathol; 1997 May; 14(2):123-32. PubMed ID: 9179973
[TBL] [Abstract][Full Text] [Related]
10. Molecular markers in bladder cancer.
Shariat SF; Karam JA; Lerner SP
Curr Opin Urol; 2008 Jan; 18(1):1-8. PubMed ID: 18090481
[TBL] [Abstract][Full Text] [Related]
11. [Non-invasive molecular detection of bladder cancer].
Hatachmi S
Harefuah; 2009 Jan; 148(1):66-9, 86. PubMed ID: 19320394
[TBL] [Abstract][Full Text] [Related]
12. Genetic and epigenetic aspects of bladder cancer.
Kim WJ; Quan C
J Cell Biochem; 2005 May; 95(1):24-33. PubMed ID: 15759278
[TBL] [Abstract][Full Text] [Related]
13. Molecular alterations in bladder cancer.
Cordon-Cardo C
Cancer Surv; 1998; 32():115-31. PubMed ID: 10489625
[TBL] [Abstract][Full Text] [Related]
14. A molecular genetic model of human bladder cancer pathogenesis.
Reznikoff CA; Belair CD; Yeager TR; Savelieva E; Blelloch RH; Puthenveettil JA; Cuthill S
Semin Oncol; 1996 Oct; 23(5):571-84. PubMed ID: 8893868
[TBL] [Abstract][Full Text] [Related]
15. Molecular pathways in invasive bladder cancer: new insights into mechanisms, progression, and target identification.
Mitra AP; Datar RH; Cote RJ
J Clin Oncol; 2006 Dec; 24(35):5552-64. PubMed ID: 17158541
[TBL] [Abstract][Full Text] [Related]
16. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in bladder cancer diagnostics.
Sanchez-Carbayo M
Clin Biochem; 2004 Jul; 37(7):562-71. PubMed ID: 15234237
[TBL] [Abstract][Full Text] [Related]
18. Genetic and epigenetic biomarkers for early detection, therapeutic effectiveness and relapse monitoring in bladder cancer.
Dumache R; David D; Kaycsa A; Minciu R; Negru S; Puiu M
Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):163-7. PubMed ID: 21682190
[TBL] [Abstract][Full Text] [Related]
19. Genetic alterations in bladder cancer and their clinical applications in molecular tumor staging.
Sugano K; Kakizoe T
Nat Clin Pract Urol; 2006 Dec; 3(12):642-52. PubMed ID: 17149381
[TBL] [Abstract][Full Text] [Related]
20. Potential for molecular-targeted therapy targeting human epidermal growth factor receptor-2 for invasive bladder cancer.
Yamada Y; Naruse K; Nakamura K; Aoki S; Taki T; Tobiume M; Zennami K; Katsuda R; Inoue Y; Noguchi H; Honda N
Oncol Rep; 2007 Jul; 18(1):3-7. PubMed ID: 17549338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
